Showing results (81-90 of 713) with videos related to
Sort By:
Pageof 72
Journal of Clinical Medicine|October 14, 2022
What More Can Be Delivered to Future Patients with Coronary Syndromes?Atsushi Tanaka, Koichi NodeCardiovascular Diabetology|March 2, 2019
Evidence-based and tailored medication in type 2 diabetes: a pathway learned from clinical trialsAtsushi Tanaka, Koichi NodeQJM : Monthly Journal of the Association of Physicians|March 4, 2025
Disease modifying therapies in heart failure: an updateAtsushi Tanaka, Koichi NodeInternational Heart Journal|August 12, 2014
Therapeutic potential of α-glucosidase inhibitors to prevent postprandial endothelial dysfunctionToru Kato, Koichi NodeCardiovascular Diabetology|October 14, 2017
Increased amputation risk with canagliflozin treatment: behind the large cardiovascular benefit?Atsushi Tanaka, Koichi NodeNihon Rinsho. Japanese Journal of Clinical Medicine|May 21, 2011
[Effects of incretin on cardiovascular disease and risk factors]Kazuhisa Kodama, Koichi NodeInternational Journal of Molecular Sciences|May 14, 2022
Collective Knowledge Used to Unveil Cardiovascular Injury Emerged during COVID-19Atsushi Tanaka, Koichi NodeHypertension Research : Official Journal of the Japanese Society of Hypertension|May 29, 2024
Associations of metabolic disorders with hypertension and cardiovascular disease: recent findings and therapeutic perspectivesAtsushi Tanaka, Koichi NodeHypertension Research : Official Journal of the Japanese Society of Hypertension|December 5, 2024
NEO-HYPERTENSION is coming: key messages from the 46th annual scientific meeting of the Japanese Society of Hypertension 2024Koichi Node, Atsushi TanakaCardiovascular Diabetology|September 4, 2020
Clinical application of sodium-glucose cotransporter 2 inhibitor into a real-world setting of heart failure careAtsushi Tanaka, Koichi NodePageof 72